Literature DB >> 10025425

Neurofibrillary pathology in Alzheimer disease with Lewy bodies: two subgroups.

M Gearing1, M Lynn, S S Mirra.   

Abstract

BACKGROUND: While NFT frequency is reportedly reduced in AD+DLB, we often encounter abundant neocortical NFTs in such cases and decided to investigate this discrepancy.
OBJECTIVE: To compare neurofibrillary tangle (NFT) frequency in Alzheimer disease with concomitant dementia with Lewy bodies (AD+DLB) with NFT frequency in "pure" AD.
METHODS: Neurofibrillary tangle frequency, as well as regional staging of neurofibrillary degeneration modified from Braak, was scored in 160 autopsy cases of primary dementia (80 AD+DLB cases and 80 pure AD cases).
RESULTS: Neurofibrillary tangle and modified Braak scores were lower in AD+DLB, as reported previously. Yet, neocortical NFT scores assumed markedly different patterns in the 2 groups (P = .001). In pure AD, NFT scores of "frequent" were predominant: more cases exhibited frequent than moderate or sparse NFTs. In AD+DLB, the distribution of NFT scores was bimodal: NFTs were either frequent or few to absent. Neocortical NFT scores in the AD+DLB group tended to parallel the severity of other types of tau cytopathology (neuropil threads and tau-positive plaque neurites).
CONCLUSIONS: Cases of AD+DLB may be divided into 2 subgroups based on the extent of neocortical neurofibrillary pathology. These findings could have implications for disease pathogenesis and treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10025425     DOI: 10.1001/archneur.56.2.203

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  6 in total

Review 1.  Distinct α-Synuclein strains and implications for heterogeneity among α-Synucleinopathies.

Authors:  Chao Peng; Ronald J Gathagan; Virginia M-Y Lee
Journal:  Neurobiol Dis       Date:  2017-07-24       Impact factor: 5.996

2.  Distinct α-synuclein strains differentially promote tau inclusions in neurons.

Authors:  Jing L Guo; Dustin J Covell; Joshua P Daniels; Michiyo Iba; Anna Stieber; Bin Zhang; Dawn M Riddle; Linda K Kwong; Yan Xu; John Q Trojanowski; Virginia M Y Lee
Journal:  Cell       Date:  2013-07-03       Impact factor: 41.582

3.  The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.

Authors:  Tanis J Ferman; Naoya Aoki; Julia E Crook; Melissa E Murray; Neill R Graff-Radford; Jay A van Gerpen; Ryan J Uitti; Zbigniew K Wszolek; Jonathan Graff-Radford; Otto Pedraza; Kejal Kantarci; Bradley F Boeve; Dennis W Dickson
Journal:  Alzheimers Dement       Date:  2017-10-31       Impact factor: 21.566

Review 4.  Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases.

Authors:  David G Coughlin; Howard I Hurtig; David J Irwin
Journal:  Mov Disord       Date:  2019-10-29       Impact factor: 10.338

Review 5.  Tau PET imaging in neurodegenerative tauopathies-still a challenge.

Authors:  Antoine Leuzy; Konstantinos Chiotis; Laetitia Lemoine; Per-Göran Gillberg; Ove Almkvist; Elena Rodriguez-Vieitez; Agneta Nordberg
Journal:  Mol Psychiatry       Date:  2019-01-11       Impact factor: 15.992

Review 6.  Dementia with Lewy bodies: disease concept and genetics.

Authors:  Manuel B Graeber; Ulrich Müller
Journal:  Neurogenetics       Date:  2003-07-26       Impact factor: 2.660

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.